2-((4-(2,5-Dimethylphenyl)-5-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-isopropyl-N-phenylacetamide

Catalog No. :
ACPUBQ231
CAS No. :
538336-66-2
Molecular Formula :
C27H28N4OS
Molecular Weight :
456.61

IUPAC Name:2-((4-(2,5-dimethylphenyl)-5-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-isopropyl-N-phenylacetamide

2-((4-(2,5-Dimethylphenyl)-5-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-isopropyl-N-phenylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-(2,5-Dimethylphenyl)-5-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-isopropyl-N-phenylacetamide
IUPAC Name2-((4-(2,5-dimethylphenyl)-5-phenyl-4H-1,2,4-triazol-3-yl)thio)-N-isopropyl-N-phenylacetamide
MDL No.MFCD03461022
Molecular FormulaC27H28N4OS
Molecular Weight456.61
SMILESO=C(N(C(C)C)C1=CC=CC=C1)CSC2=NN=C(C3=CC=CC=C3)N2C4=CC(C)=CC=C4C
InChI KeyJRFSSEMWUYCBPL-UHFFFAOYSA-N
SynonymSALOR-INT L445975-1EA;2-([4-(2,5-DIMETHYLPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-ISOPROPYL-N-PHENYLACETAMIDE
CAS No.538336-66-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPUBQ231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUBQ231 route product structure diagram
    ACPUBQ231538336-66-2
Inquiry

2. ACPUBQ231 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEXWR681 route compound structure diagram
    ACEXWR681768-52-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPUBQ231 route product structure diagram
    ACPUBQ231538336-66-2
Inquiry

Comments (0)